What drove the intraday move in 6L9.F stock today?

The intraday move was volume-driven: 6L9.F stock hit **€0.025** on XETRA with **3,500.00** shares traded, far above the **279.00** average. Thin liquidity and potential news or order chatter often cause spikes in such small-cap med-device names.

What is Meyka AI's rating and how should I use it for 6L9.F stock?

Meyka AI rates 6L9.F **57.52 (C+)** with a **HOLD** suggestion. The grade blends sector, growth, metrics, and consensus. Use it as one data point alongside your own due diligence and risk controls.

What are realistic price targets and risks for 6L9.F stock?

Meyka suggests a near-term target **€0.050** and a 12-month base-case **€0.080**, implying upside but with high volatility. Main risks: negative EPS **-0.55**, long receivables, and thin intraday liquidity that can cause sharp reversals.

DE Stocks

6L9.F ViewRay surges 2400.00% intraday on XETRA 30 Jan 2026: watch volume spike

ByDanny Kontos January 30, 2026

ViewRay, Inc. (6L9.F stock) surged 2400.00% intraday on XETRA to €0.025 on 30 Jan 2026 as trade volume jumped to 3,500.00 shares, well above the 279.00 average. The move pushed the price from a €0.001 open to a €0.025 high, creating a high-volume breakout in a thinly traded name. Traders should note the extreme gap versus the 50-day average of €0.31916 and the 200-day average of €2.71739, indicating the move is volume-driven and not yet supported by sustained price structure. We examine drivers, valuation, and near-term scenarios for 6L9.F stock on XETRA in Germany.